Drug recall · February 5, 2020
Nystatin Oral Suspension recall
Why: Subpotent: Out of specification for assay at the 12-month time point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai, Pharmaceutical Associates, Inc. Greenville, SC 29605. NDC 0121-0810-16
- Lots / codes
Lots: BB70, BB71 Exp. May 2020
- Quantity
- 6288 16 oz bottles
- Company
- Pharmaceutical Associates Inc, Greenville, SC
- Distribution
- Distributed Nationwide in the US
- Initiated
- January 14, 2020 · Voluntary: Firm initiated
- Classified
- February 3, 2020
- Reported
- February 5, 2020
- Ended
- June 3, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nystatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.